Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 21 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MCK | $116.0B | 25.9× | 18.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 0.4× | 672 |
| COR | $63.1B | 41.6× | 18.1× | 0.2× | 9.3% | 3.6% | 0.5% | 103% | 17.0% | 0.9× | — |
| CAH | $58.0B | 34.6× | 14.9× | 0.2× | 14.2% | 3.8% | 0.7% | -59.5% | -59.5% | -1.4× | 463 |
| SYY | $40.8B | 22.6× | 9.9× | 0.5× | 3.9% | 18.5% | 2.1% | 65.9% | 65.9% | -0.5× | 516 |
| USFD | $22.4B | 35.2× | 16.6× | 0.6× | 4.1% | 17.4% | 1.7% | 15.7% | 7.1% | 3.1× | 154 |
| PFGC | $15.6B | 43.3× | 14.3× | 0.2× | 7.2% | 11.9% | 0.5% | 7.3% | 3.6% | 3.4× | 125 |
| DPZ | $10.3B | 17.9× | — | 2.1× | 5.0% | 40.0% | 12.2% | -15.4% | -15.5% | — | 181 |
| CHEF | $4.5B | 62.0× | 25.9× | 1.1× | 9.4% | 24.2% | 1.7% | 12.0% | 5.3% | 3.2× | 66 |
| SEB | $3.7B | 7.6× | 8.1× | 0.4× | 7.1% | 7.1% | 5.1% | 9.6% | 8.1% | 1.4× | 32 |
| ASH | $3.4B | — | — | 1.9× | -13.7% | 30.1% | -46.3% | -44.4% | -25.7% | — | 73 |
| HWKN | $3.2B | 39.0× | 19.6× | 2.9× | 11.2% | 22.6% | 7.5% | 15.3% | 10.5% | 1.4× | 55 |
| CENT | $2.9B | 17.9× | 9.4× | 0.9× | -2.2% | 31.9% | 5.2% | 10.3% | 5.9% | 0.9× | 35 |
| UNFI | $2.8B | 34.2× | 8.3× | 0.1× | -2.0% | 13.5% | 0.3% | 5.2% | 2.6% | 3.0× | 63 |
| ANDE | $2.2B | — | — | 0.2× | -2.2% | 6.5% | 0.9% | 7.7% | 4.7% | — | 72 |
| VSTS | $2.0B | — | 14.9× | 0.7× | -2.5% | — | -1.5% | -4.6% | -2.0% | 5.4× | 54 |
| WKC | $1.9B | — | — | 0.1× | -12.5% | 2.6% | -1.7% | -47.3% | -30.8% | — | 63 |
| HLF | $1.4B | 5.9× | 5.2× | 0.3× | 0.9% | 77.9% | 4.5% | -44.3% | 15.5% | 2.8× | 33 |
| UVV | $1.0B | 31.9× | 8.4× | 0.4× | -1.3% | 16.4% | 1.1% | 2.3% | 1.4% | 3.8× | 45 |
| CAPL | $859M | 22.1× | 8.3× | 0.2× | -10.6% | 11.0% | 1.1% | — | — | 3.7× | 11 |
| AGCC | $635M | 387.7× | — | — | 145% | 30.4% | 9.8% | 6.2% | 2.7% | — | — |
| WEYS | $501M | 21.8× | 12.7× | 1.8× | -4.9% | 43.2% | 8.4% | 9.6% | 9.6% | -3.0× | 16 |
| NUS | $226M | 1.5× | 1.8× | 0.1× | -14.3% | 69.4% | 10.8% | 19.9% | 15.6% | -0.1× | 27 |
Peers = companies sharing UVV's sector (Wholesale-Farm Product Raw Materials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2025, FY2026). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $41.44 today, the market must believe free cash flow compounds -5.2%/yr for a decade (off $172.3M on the 3-yr avg basis).
On the basis ($164.5M) the requirement is -4.6%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's -5.2% is more optimistic than its 9-yr track record.
Default is 7.7% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.02B shares (market data) · net debt $842.1M
mean -41.2% · volatility σ 118% · implied rate exceeded in 1/5 yrs
Central path = implied -5.2%/yr growth; shaded band = ±1σ (118%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (101%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $81.3M dividends + $0 buybacks = $81.3M returned on $80.3M FCF.
5 consecutive years of dividend increases · 6%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $62.2M is below the $116.3M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2014-03-31 (10-K). The cash figure is from 2026-03-31, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~8.2% on $904.3M of debt.
Cash of $62.2M is below short-term debt of $287.6M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2026
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it. This year they exceeded net income, so the ribbons are capped at earnings and understate what was actually returned.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.89B 100.0% | $2.92B 100.0% | $2.72B 100.0% | $2.55B 100.0% | $2.09B 100.0% | $1.97B 100.0% | $1.89B 100.0% | $2.21B 100.0% | $2.02B 100.0% | $2.05B 100.0% |
| Cost of Revenue | $2.41B 83.6% | $2.40B 82.1% | $2.21B 81.3% | $2.11B 82.8% | $1.69B 81.0% | $1.60B 81.3% | $1.55B 82.1% | $1.82B 82.3% | $1.66B 82.3% | $1.68B 81.9% |
| Selling, General & Admin | $300.7M 10.4% | $305.3M 10.4% | $310.6M 11.4% | $277.2M 10.9% | $240.7M 11.5% | $219.8M 11.2% | $222.9M 11.8% | $225.1M 10.2% | $201.1M 10.0% | $211.9M 10.4% |
| Operating Income | $168.5M 5.8% | $232.8M 8.0% | $222.0M 8.2% | $181.1M 7.1% | $160.3M 7.7% | $147.8M 7.5% | $126.4M 6.7% | $161.2M 7.3% | $170.8M 8.5% | $178.4M 8.7% |
| Interest Expense | $74.0M 2.6% | $79.6M 2.7% | $66.3M 2.4% | $49.3M 1.9% | $27.7M 1.3% | $25.0M 1.3% | $19.9M 1.0% | $17.5M 0.8% | $15.6M 0.8% | $16.3M 0.8% |
| Interest & Investment Income | $2.0M 0.1% | $3.5M 0.1% | $4.5M 0.2% | $6.0M 0.2% | $917K 0.0% | $325K 0.0% | $1.6M 0.1% | $1.5M 0.1% | $1.7M 0.1% | $1.4M 0.1% |
| Other Income (Expense), net | $2.8M 0.1% | $2.6M 0.1% | $3.1M 0.1% | $1.8M 0.1% | $2.7M 0.1% | -$440K -0.0% | $986K 0.1% | $832K 0.0% | $662K 0.0% | -$50K -0.0% |
| Pretax Income | $102.7M 3.6% | $154.2M 5.3% | $164.1M 6.0% | $142.0M 5.6% | $142.3M 6.8% | $125.7M 6.4% | $113.3M 6.0% | $151.3M 6.8% | $166.7M 8.3% | $169.2M 8.3% |
| Income Tax Expense | $46.7M 1.6% | $40.9M 1.4% | $31.1M 1.1% | $11.7M 0.5% | $38.7M 1.8% | $29.4M 1.5% | $35.3M 1.9% | $41.2M 1.9% | $50.5M 2.5% | $56.7M 2.8% |
| Net Income | $33K 0.0% | $95K 0.0% | $120K 0.0% | $124K 0.0% | $87K 0.0% | $87.4M 4.4% | $71.7M 3.8% | $104.1M 4.7% | $105.7M 5.2% | $106.3M 5.2% |
| Per Share | ||||||||||
| EPS (Basic) | $1.30 | $3.81 | $4.81 | $5.01 | $3.50 | $3.55 | $2.87 | $4.14 | $4.18 | $0.89 |
| EPS (Diluted) | $1.30 | $3.78 | $4.78 | $4.97 | $3.47 | $3.53 | $2.86 | $4.11 | $4.14 | $0.88 |
| Weighted Avg Shares (Basic) | 25.0M | 24.9M | 24.9M | 24.8M | 24.8M | 24.7M | 25.0M | 25.1M | 25.3M | 23.4M |
| Weighted Avg Shares (Diluted) | 25.2M | 25.1M | 25.0M | 24.9M | 24.9M | 24.8M | 25.1M | 25.3M | 25.5M | 23.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 15-yr range · 70th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 15-yr history.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
ROE 2% against ROIC 1% — 1% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 21.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 82.3 | 82.1 | 81.3 | 81.0 | 82.8 | 81.3 | 82.1 | 83.6 |
| SG&A | 10.2 | 11.8 | 11.2 | 11.5 | 10.9 | 11.4 | 10.4 | 10.4 |
| Operating Income | 7.3 | 6.7 | 7.5 | 7.7 | 7.1 | 8.2 | 8.0 | 5.8 |
| Income Tax | 1.9 | 1.9 | 1.5 | 1.8 | 0.5 | 1.1 | 1.4 | 1.6 |
| Net Income | 4.7 | 3.8 | 4.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on UVV: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns -3.01pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2020 | 5.3% | 7.7% (today's — no rate published for this year) | -2.3pts |
| FY2021 | 5.8% | 7.7% (today's — no rate published for this year) | -1.9pts |
| FY2022 | 5.5% | 5.0% | 0.5pts |
| FY2023 | 5.7% | 5.9% | -0.2pts |
| FY2024 | 6.2% | 6.7% | -0.5pts |
| FY2025 | 6.9% | 7.3% | -0.4pts |
| FY2026 | 5.0% | 7.1% | -2.1pts |
| Now | 1.4% | 7.7% | -6.3pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2017 | 18.1% | 8.7% | 5.2% |
| FY2018 | 17.7% | 8.5% | 5.2% |
| FY2019 | 17.7% | 7.3% | 4.7% |
| FY2020 | 17.9% | 6.7% | 3.8% |
| FY2021 | 18.7% | 7.5% | 4.4% |
| FY2022 | 19.0% | 7.7% | 4.1% |
| FY2023 | 17.2% | 7.1% | 4.9% |
| FY2024 | 18.7% | 8.2% | 4.4% |
| FY2025 | 17.9% | 8.0% | 3.3% |
| FY2026 | 16.4% | 5.8% | 1.1% |
Return on equity (2%) and return on invested capital (1%) are within a couple of points in FY2026, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
$173M of goodwill — 7% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
Margins have compressed 2 years running even as the spread stayed positive.
Cash conversion of 0.69x sits below the level that would make the earnings clearly cash-backed.
The cash conversion cycle could not be computed — receivables, inventory or cost of revenue is not reported — so the earliest accrual warning is not part of this verdict.
Stressed coverage of 1.6x sits between comfortable and thin.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 2.28x |
| 5% | 2.16x |
| 10% | 2.05x |
| 15% | 1.93x |
| 20% | 1.82x |
| 25% | 1.71x |
| 30% | 1.59x |
| 35% | 1.48x |
| 40% | 1.37x |
| 45% | 1.25x |
| 50% | 1.14x |
| 55% | 1.02x |
| 60% | 0.91x |
This schedule comes from a filing dated 2014-03-31, 4597 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2014-03-31 (10-K); cash from the 2026-03-31 balance sheet; FCF from FY2026.
Balance sheet at 2026-03-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Net debt is 4.0x EBITDA, so coverage today depends on earnings holding up rather than on the balance sheet.
At $41.44, free cash flow must compound -4.93%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2022 | −105.4% | −4.9% |
| FY2026 | −69.6% | −4.9% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
The implied rate of -4.93% has not been achieved in any of the last 2 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $33M | $33M |
| Share-based comp | $7M | $40M |
| Other non-cash & working capital | $89M | $129M |
| Operating cash flow | $129M | $129M |
| Capex | −$49M | $80M |
| Free cash flow | $80M | $80M |
| FCF after SBC | $73M | $73M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2021 | 3.9% | 7.9% | 4.0 points |
| FY2022 | 6.4% | 4.9% | -1.5 points |
| FY2023 | 21.9% | 4.3% | -17.6 points |
| FY2024 | 6.7% | 30.6% | 23.9 points |
| FY2025 | 7.4% | 19.2% | 11.8 points |
| FY2026 | -1.3% | -9.9% | -8.6 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2020 | 65.7 days | not reported | 32.9 days | 32.8 days |
| FY2021 | 68.2 days | not reported | 31.9 days | 36.4 days |
| FY2022 | 67.3 days | not reported | 58.6 days | 8.7 days |
| FY2023 | 57.6 days | not reported | not reported | not reported |
| FY2024 | 70.4 days | not reported | not reported | not reported |
| FY2025 | 78.2 days | not reported | not reported | not reported |
| FY2026 | 71.3 days | not reported | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2020 | 2.9 percent |
| FY2021 | -5.7 percent |
| FY2022 | 1.6 percent |
| FY2023 | 5.1 percent |
| FY2024 | 6.6 percent |
| FY2025 | -7.8 percent |
| FY2026 | -3.5 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2026) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Wigner Preston Douglas Chairman, President & CEO | Tax withholding | 6,469 | $41.68 | $270k |
| 2026-08-10 | Freeman Lennart R. Director | Open-market sale | 1,782 | $49.82 | $89k |
| 2026-08-04 | Cantor Diana F Director | Grant | 2,650 | $0.00 | $0 |
| 2026-08-04 | Schick Arthur J. Jr. Director | Grant | 2,650 | $0.00 | $0 |
| 2026-08-04 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Grant |
| 2,650 |
| $0.00 |
| $0 |
| 2026-08-04 | Sledd Robert C Director | Grant | 2,650 | $0.00 | $0 |
| 2026-08-04 | Manolios Fotini Emanuel Director | Grant | 2,650 | $0.00 | $0 |
| 2026-08-04 | Trojan Greg Director | Grant | 4,580 | $0.00 | $0 |
| 2026-08-04 | Freeman Lennart R. Director | Grant | 2,650 | $0.00 | $0 |
| 2026-08-04 | Williams Jacqueline T. Director | Grant | 2,650 | $0.00 | $0 |
| 2026-06-03 | Sledd Robert C Director | Open-market sale | 2,845 | $54.13 | $154k |
| 2026-06-02 | 3 co-filers VP & Controller | Grant | 2,210 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers VP, Gen. Counsel & Secretary | Grant | 7,980 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & CFO | Grant | 5,315 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Chairman, President & CEO | Grant | 20,890 | $0.00 | $0 |
| 2026-06-02 | Santos Godoi Tatiana Chief Human Resources Officer | Grant | 2,515 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & Sales Director | Grant | 2,960 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers VP, Ingredients | Grant | 3,825 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & COO | Grant | 10,765 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers VP, Gen. Counsel & Secretary | Grant | 2,413 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers VP & Controller | Grant | 1,560 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & Sales Director | Grant | 1,121 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers VP, Ingredients | Grant | 3,168 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & CFO | Grant | 463 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & COO | Grant | 9,481 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Chairman, President & CEO | Grant | 4,436 | $0.00 | $0 |
| 2026-06-02 | 3 co-filers Senior VP & Sales Director | Tax withholding | 484 | $54.38 | $26k |
| 2026-06-02 | 3 co-filers VP, Ingredients | Tax withholding | 1,366 | $54.38 | $74k |
| 2026-06-02 | 3 co-filers Senior VP & CFO | Tax withholding | 183 | $54.38 | $10k |
| 2026-06-02 | 3 co-filers Senior VP & COO | Tax withholding | 4,276 | $54.38 | $233k |
| 2026-06-02 | 3 co-filers VP & Controller | Tax withholding | 673 | $54.38 | $37k |
| 2026-06-02 | 3 co-filers VP, Gen. Counsel & Secretary | Tax withholding | 1,041 | $54.38 | $57k |
| 2026-06-02 | 3 co-filers Chairman, President & CEO | Tax withholding | 2,001 | $54.38 | $109k |
| 2026-06-01 | Claiborne Catherine H VP, Gen. Counsel & Secretary | Tax withholding | 1,277 | $54.13 | $69k |
| 2026-06-01 | Hentschke Airton L Senior VP & COO | Tax withholding | 9,485 | $54.13 | $513k |
| 2026-06-01 | Wigner Preston Douglas Chairman, President & CEO | Tax withholding | 2,461 | $54.13 | $133k |
| 2026-06-01 | Starke Mckeen Senior VP & Sales Director | Tax withholding | 733 | $54.13 | $40k |
| 2026-06-01 | O'Keefe John Patrick VP, Ingredients | Tax withholding | 1,685 | $54.13 | $91k |
| 2026-06-01 | Bleicher Scott J VP & Controller | Tax withholding | 882 | $54.13 | $48k |
| 2026-06-01 | Diel Steven S. Senior VP & CFO | Tax withholding | 248 | $54.13 | $13k |